TNGX Stock Price
Tango Therapeutics, Inc.
TNGX stock price is $22.83 (+2.88% on the day), giving Tango Therapeutics, Inc. a market cap of $3.74B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
TNGX Stock Overview
- Price
- $22.83
- Previous close
- $22.19
- Open
- $22.27
- Market cap
- $3.74B
- P/E ratio
- -36.8
- 52-week range
- $6.69 - $34.39
- 1-year price target
- $43.42
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 53
About Tango Therapeutics, Inc.
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors; TNG462, which is in Phase 1/2 clinical trial for non- central nervous system cancers including pancreatic and lung cancer; TNG456, a brain-penetrant PRMT5 inhibitor, for central nervous system cancers including glioblastoma; and TNG260, a co-repressor of repressor element-1 silencing transcription (CoREST) inhibitor to reverse the immune evasion effect of STK11 loss-of-function mutations. The company has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. Tango Therapeutics, Inc. was founded in 2017 and is headquartered in Boston, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TNGX | $22.83 | +2.9% | 238.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tango Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW